A recent study conducted in Sweden found that GLP-1 agonists such as Ozempic and Wegovy may help reduce alcohol consumption and related harms in individuals diagnosed with alcohol use disorder. Here ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback